Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
Cerilliant
Harvard Business School
Julphar
Citi
Covington
Accenture
Chinese Patent Office
McKinsey

Generated: February 22, 2018

DrugPatentWatch Database Preview

NPH ILETIN II Drug Profile

« Back to Dashboard

When do Nph Iletin Ii patents expire, and when can generic versions of Nph Iletin Ii launch?

Nph Iletin Ii is a drug marketed by Lilly and is included in two NDAs.

The generic ingredient in NPH ILETIN II is insulin susp isophane purified pork. There are thirty-nine drug master file entries for this compound. Additional details are available on the insulin susp isophane purified pork profile page.
Summary for NPH ILETIN II
US Patents:0
Applicants:1
NDAs:2
Clinical Trials: 1
Drug Prices:see details
DailyMed Link:NPH ILETIN II at DailyMed
Drug patent expirations by year for NPH ILETIN II

US Patents and Regulatory Information for NPH ILETIN II

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly NPH ILETIN II insulin susp isophane purified beef INJECTABLE;INJECTION 018479-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lilly NPH ILETIN II (PORK) insulin susp isophane purified pork INJECTABLE;INJECTION 018345-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
US Department of Justice
Dow
Queensland Health
AstraZeneca
Harvard Business School
Fuji
UBS
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot